Article info

Download PDFPDF

Improvement of asymmetric thyroid eye disease with teprotumumab

Authors

  1. Correspondence to Dr Shoaib Ugradar, Orbital and Ophthalmic Plastic Surgery, Jules Stein Eye Institute, Los Angeles, CA 90095, USA; ugradsahi{at}aol.com
View Full Text

Citation

Ugradar S, Wang Y, Mester T, et al
Improvement of asymmetric thyroid eye disease with teprotumumab

Publication history

  • Received November 2, 2020
  • Revised December 29, 2020
  • Accepted January 7, 2021
  • First published February 12, 2021.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.